SCHEMBL2767466

SCHEMBL2767466

COc1cc(F)c(N2CCC(/C=C\Cc3ccccc3)CC2)cc1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.46
ACACB O00763 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KDM4E B2RXH2 4/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
NPY2R P49146 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36
DRD4 P21917 2/20 0.36
DRD2 P14416 1/20 0.36
MAPK1 P28482 2/20 0.36
BCHE P06276 2/20 0.36
CHRM4 P08173 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2767469 1.00 FFAR4 (0.46) FFAR4ACACBALDH1A1KDM4EGAA
SCHEMBL2767675 0.82 LMNA (0.35) ALDH1A1SMN1; SMN2NPY2RBCHECHRM4
SCHEMBL2767679 0.82 LMNA (0.35) ALDH1A1SMN1; SMN2NPY2RBCHECHRM4
SCHEMBL2768381 0.81 SLC6A2 (0.55) FFAR4ALDH1A1SMN1; SMN2SLC6A2SLC6A4
SCHEMBL2767116 0.77 FFAR4 (0.48) FFAR4SLC6A2SLC6A4CHRM4
SCHEMBL2766678 0.76 FFAR4 (0.54) FFAR4ACACBALDH1A1GAASMN1; SMN2
SCHEMBL2766148 0.74 ADRA1D (0.68) ADRA1DADRA1AADRA1B
SCHEMBL2766487 0.70 FFAR4 (0.59) FFAR4ACACBALDH1A1KDM4EGAA
SCHEMBL2767625 0.70 KMT2A (0.65) ALDH1A1GAASMN1; SMN2TDP1L3MBTL1
SCHEMBL2767962 0.70 KDM4E (0.49) ALDH1A1KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA FFAR4 2828/4885ACACB 350/4885ALDH1A1 2953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.